Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Events

06 Jun 2016 - 09 Jun 2016
22 Jun 2016 - 24 Jun 2016
04 Jul 2016 - 06 Jul 2016

Novel Cell Sieve Reduces Risk of Contamination During Filtration of Cell Suspensions and Primary Cell Isolates

By BiotechDaily International staff writers
Posted on 15 Aug 2013
Print article
Image: EASYstrainer cell sieve for filtration of cell suspensions and primary cell isolates (Photo courtesy of Greiner Bio-One).
Image: EASYstrainer cell sieve for filtration of cell suspensions and primary cell isolates (Photo courtesy of Greiner Bio-One).
A novel sterile, single-use cell sieve is ideal for preparing single cells for flow cytometry and to separate individual cells after organ digestion as part of the primary cell extraction process.

Greiner Bio-One (Kremsmuenster, Austria), a company that has focused on the development, production, and distribution of plastic laboratory products, has introduced EASYstrainer, a cell sieve for the filtration of cell suspensions.

To prevent sterile filter material from becoming contaminated through accidental contact EASYstrainer was designed with a circumferential mantle surface and handle fitted directly on the sieve. The unit is sealed in blister packaging that ensures reliable, aseptic removal of sieves from the pack.

The EASYstrainer features a venting slot between the collection tube and the attached cell sieve. Air in the tube escapes through this slot during the rapid filtration step, and overflow is avoided. This special property prevents the accumulation of filtration liquid between the sieve and tube and thus the associated risk of contamination.

EASYstrainer is suitable for all standard 50 ml tubes and is available in mesh widths of 40, 70, and 100 microliters.

Related Links:
Greiner Bio-One


Print article

Channels

Genomics/Proteomics

view channel
Image: A dark field photomicrograph showing the spirochete bacterium Borrelia burgdorferi, the pathogen responsible for causing Lyme disease (Photo courtesy of the CDC).

Statins May Help Block Transmission of Lyme Disease

A recent study found that treatment with cholesterol-lowering statins reduced the number of Borrelia burgdorferi bacteria in rodents, which helped to block transmission of Lyme disease. Lyme disease... Read more

Drug Discovery

view channel

Experimental Small-Molecule Anticancer Drug Blocks RAS-binding Domains

The experimental small-molecule anticancer drug rigosertib was shown to block tumor growth by acting as an RAS-mimetic and interacting with the RAS binding domains of RAF kinases, resulting in their inability to bind to RAS, which inhibited the RAS-RAF-MEK pathway. Oncogenic activation of RAS genes due to point mutations... Read more

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Lab Technologies

view channel

Huge Modifiable Biomedical Database to Be Available on the Wikidata Site

Genome researchers are exploiting the power of the open Internet community Wikipedia database to create a comprehensive resource for geneticists, molecular biologists, and other interested life scientists. While efficiency in generating scientific data improves almost daily, applying meaningful relationships between... Read more

Business

view channel

European Biotech Agreement to Promote Antigen-Drug Conjugation Technology

Two European biotech companies have joined forces to exploit and commercialize an innovative, site-specific ADC (antigen-drug conjugate) conjugation technology. ProBioGen (Berlin, Germany), a company specializing in the development and manufacture of complex glycoproteins and Eucodis Bioscience (Vienna, Austria), a... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.